Clinical Trials in Lu'an, China
1 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
Acute Ischemic Stroke
Boehringer Ingelheim1,325 enrolled224 locationsNCT07361302
Recruiting
Not Applicable
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion
Brain DiseasesStrokeCerebrovascular Disorders+5 more
The Second Hospital of Anhui Medical University282 enrolled6 locationsNCT07185022
Recruiting
China Liver Cancer Clinical Registry Cohort Database (HEAL)
Liver Cancer
Anhui Provincial Hospital10,000 enrolled38 locationsNCT06777485
Recruiting
Phase 2
A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma
Gastroesophageal Adenocarcinoma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.204 enrolled39 locationsNCT06767800
Recruiting
Not Applicable
Statins for Treatment of Primary Intracerebral Hemorrhage
Cerebrovascular DisordersIntracranial HemorrhagesIntracerebral haemorrhage+1 more
The Second Hospital of Anhui Medical University264 enrolled22 locationsNCT07088250
Recruiting
Phase 2
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
Non Alcoholic Steatohepatitis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.120 enrolled53 locationsNCT06569524
Recruiting
Phase 1
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.150 enrolled20 locationsNCT06115902